Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Individual Batches of ATG-F in Kidney Transplant Recipients: Multicentre, Prospective, Observational Study

NCT02392312 is registered in ClinicalTrials.gov with Astellas Pharma China, Inc. as lead sponsor.

NCT NCT02392312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Individual Batches of ATG-F in Kidney Transplant Recipients: Multicentre, Prospective, Observational Study
Lead sponsor
Astellas Pharma China, Inc.
Phase
Observational
Overall status
Completed
Start date
January 21, 2015
Completion date
March 16, 2018
Enrollment
950 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant recipients